Sante Tura

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Brusamolino Ercole; Bacigalupo Andrea; Barosi Giovanni; Biti Giampaolo; Gobbi Paolo G; Levis Alessandro; Marchetti Monia; Santoro Armando; Zinzani Pier Luigi; Tura Sante
Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up.
Morra Enrica; Barosi Giovanni; Bosi Alberto; Ferrara Felicetto; Locatelli Franco; Marchetti Monia; Martinelli Giovanni; Mecucci Cristina; Vignetti Marco; Tura Sante
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.
Tosi Patrizia; Barosi Giovanni; Lazzaro Carlo; Liso Vincenzo; Marchetti Monia; Morra Enrica; Pession Andrea; Rosti Giovanni; Santoro Antonio; Zinzani Pier Luigi; Tura Sante
Consensus conference on the management of tumor lysis syndrome.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Sante Tura (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Brusamolino Ercole; Bacigalupo Andrea; Barosi Giovanni; Biti Giampaolo; Gobbi Paolo G; Levis Alessandro; Marchetti Monia; Santoro Armando; Zinzani Pier Luigi; Tura Sante
Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up.
Haematologica 2009;94(4):550-65.
2009: Morra Enrica; Barosi Giovanni; Bosi Alberto; Ferrara Felicetto; Locatelli Franco; Marchetti Monia; Martinelli Giovanni; Mecucci Cristina; Vignetti Marco; Tura Sante
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.
Haematologica 2009;94(1):102-12.
2008: Tosi Patrizia; Barosi Giovanni; Lazzaro Carlo; Liso Vincenzo; Marchetti Monia; Morra Enrica; Pession Andrea; Rosti Giovanni; Santoro Antonio; Zinzani Pier Luigi; Tura Sante
Consensus conference on the management of tumor lysis syndrome.
Haematologica 2008;93(12):1877-85.
2008: Zinzani Pier Luigi; Martelli Maurizio; Poletti Venerino; Vitolo Umberto; Gobbi Paolo G; Chisesi Tommaso; Barosi Giovanni; Ferreri Andrés J M; Marchetti Monia; Pimpinelli Nicola; Tura Sante;
Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2008;93(9):1364-71.
2008: Angelucci Emanuele; Barosi Giovanni; Camaschella Clara; Cappellini Maria Domenica; Cazzola Mario; Galanello Renzo; Marchetti Monia; Piga Antonio; Tura Sante
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders.
Haematologica 2008;93(5):741-52.
2008: Tosi Patrizia; Terragna Carolina; Testoni Nicoletta; Zamagni Elena; Renzulli Matteo; Tacchetti Paola; Montanari Elena; Perrone Giulia; Ceccolini Michela; Brioli Annamaria; Pallotti Maria C; Tura Sante; Baccarani Michele; Cavo Michele
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation.
European journal of haematology 2008;80(1):31-6.
2007: Cavo Michele; Tosi Patrizia; Zamagni Elena; Cellini Claudia; Tacchetti Paola; Patriarca Francesca; Di Raimondo Francesco; Volpe Ettore; Ronconi Sonia; Cangini Delia; Narni Franco; Carubelli Affra; Masini Luciano; Catalano Lucio; Fiacchini Mauro; de Vivo Antonio; Gozzetti Alessandro; Lazzaro Antonio; Tura Sante; Baccarani Michele
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2434-41.
2006: Brugiatelli Maura; Bandini Giuseppe; Barosi Giovanni; Lauria Francesco; Liso Vincenzo; Marchetti Monia; Mauro Francesca Romana; Meloni Giovanna; Zinzani Pier Luigi; Tura Sante;
Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2006;91(12):1662-73.
2006: Tosi Patrizia; Zamagni Elena; Cangini Delia; Tacchetti Paola; Di Raimondo Francesco; Catalano Lucio; D'Arco Alfonso; Ronconi Sonia; Cellini Claudia; Offidani Massimo; Perrone Giulia; Ceccolini Michela; Brioli Annamaria; Tura Sante; Baccarani Michele; Cavo Michele
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
Blood 2006;108(12):3951-2.
2006: Catani Lucia; Fagioli Maria Elena; Tazzari Pier Luigi; Ricci Francesca; Curti Antonio; Rovito Manuela; Preda Paola; Chirumbolo Gabriella; Amabile Marilina; Lemoli Roberto M; Tura Sante; Conte Roberto; Baccarani Michele; Vianelli Nicola
Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
Experimental hematology 2006;34(7):879-87.
2006: Lorenzini S; Andreone P; Gramenzi A; Morelli C; Zinzani P L; Grazi G L; Pileri S; Baccarani M; Tura S; Bernardi M
Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases.
Transplantation proceedings 2006;38(5):1477-80.
2006: Tosi Patrizia; Zamagni Elena; Cellini Claudia; Parente Raffaele; Cangini Delia; Tacchetti Paola; Perrone Giulia; Ceccolini Michela; Boni Paola; Tura Sante; Baccarani Michele; Cavo Michele
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
European journal of haematology 2006;76(5):399-404.
2006: Barosi Giovanni; Carella Angelo; Lazzarino Mario; Marchetti Monia; Martelli Maurizio; Rambaldi Alessandro; Tarella Corrado; Vitolo Umberto; Zinzani Pier Luigi; Tura Sante;
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2006;91(1):96-103.
2005: Barosi Giovanni; Carella Angelo; Lazzarino Mario; Marchetti Monia; Martelli Maurizio; Rambaldi Alessandro; Tarella Corrado; Vitolo Umberto; Zinzani Pier Luigi; Tura Sante
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation.
Haematologica 2005;90(9):1236-57.
2005: Cavo Michele; Zamagni Elena; Tosi Patrizia; Tacchetti Paola; Cellini Claudia; Cangini Delia; de Vivo Antonio; Testoni Nicoletta; Nicci Chiara; Terragna Carolina; Grafone Tiziana; Perrone Giulia; Ceccolini Michela; Tura Sante; Baccarani Michele;
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
Blood 2005;106(1):35-9.
2005: Gale Robert Peter; Horowitz Mary M; Talpaz Moshe; Scheinberg David A; Molldrem Jeffrey; Li Zihai; Baccarani Michele; Goldman John M; Tura Sante
Immune therapy of chronic myelogenous leukemia.
Leukemia research 2005;29(5):583-6.
2005: Lemoli Roberto M; Bertolini Francesco; Cancedda Ranieri; De Luca Michele; Del Santo Antonio; Ferrari Giuliana; Ferrari Sergio; Martino Gianvito; Mavilio Fulvio; Tura Sante
Stem cell plasticity: time for a reappraisal?
Haematologica 2005;90(3):360-81.
2005: Tosi Patrizia; Zamagni Elena; Cellini Claudia; Plasmati Rosaria; Cangini Delia; Tacchetti Paola; Perrone Giulia; Pastorelli Francesca; Tura Sante; Baccarani Michele; Cavo Michele
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
European journal of haematology 2005;74(3):212-6.
2005: Vianelli Nicola; Galli Monica; de Vivo Antonio; Intermesoli Tamara; Giannini Benedetta; Mazzucconi Maria Gabriella; Barbui Tiziano; Tura Sante; Baccaranion Michele;
Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Haematologica 2005;90(1):72-7.
2004: Tenedini Elena; Fagioli Maria Elena; Vianelli Nicola; Tazzari Pier Luigi; Ricci Francesca; Tagliafico Enrico; Ricci Paolo; Gugliotta Luigi; Martinelli Giovanni; Tura Sante; Baccarani Michele; Ferrari Sergio; Catani Lucia
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells.
Blood 2004;104(10):3126-35.
2004: Zinzani Pier Luigi; Pulsoni Alessandro; Gentilini Patrizia; Visani Giuseppe; Perrotti Alessio; Molinari Anna Lia; Guardigni Luciano; Tani Monica; Villivà Nicoletta; Stefoni Vittorio; Alinari Lapo; Martelli Maurizio; Bonifazi Francesca; Pileri Stefano; Tura Sante; Baccarani Michele
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2004;45(9):1815-9.
2004: Tosi Patrizia; Zamagni Elena; Cellini Claudia; Cangini Delia; Tacchetti Paola; Tura Sante; Baccarani Michele; Cavo Michele
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
European journal of haematology 2004;73(2):98-103.
2004: Visani Giuseppe; Isidori Alessandro; Grafone Tiziana; Tosi Patrizia; Santini Valeria; Malagola Michele; Martinelli Giovanni; Piccaluga Pier Paolo; Gaziev Djavid; Ottaviani Emanuela; Sparaventi Giovanni; Tura Sante
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?
Leukemia & lymphoma 2004;45(7):1361-4.
2004: Cavo Michele; Zamagni Elena; Tosi Patrizia; Cellini Claudia; Cangini Delia; Tacchetti Paola; Testoni Nicoletta; Tonelli Michela; de Vivo Antonio; Palareti Gualtiero; Tura Sante; Baccarani Michele
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
Haematologica 2004;89(7):826-31.
2004: Zinzani Pier Luigi; Pulsoni Alessandro; Perrotti Alessio; Soverini Simona; Zaja Francesco; De Renzo Amalia; Storti Sergio; Lauta Vito Michele; Guardigni Luciano; Gentilini Patrizia; Tucci Alessandra; Molinari Anna Lia; Gobbi Marco; Falini Brunangelo; Fattori Pier Paolo; Ciccone Fabrizio; Alinari Lapo; Martelli Maurizio; Pileri Stefano; Tura Sante; Baccarani Michele
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2654-61.
2004: Barosi Giovanni; Boccadoro Mario; Cavo Michele; Corradini Paolo; Marchetti Monia; Massaia Massimo; Merlini Giampaolo; Tosi Patrizia; Tura Sante;
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO).
Haematologica 2004;89(6):717-41.
2004: Zinzani Pier Luigi; Tani Monica; Gabriele Annalisa; Gherlinzoni Filippo; De Vivo Antonello; Ricci Paolo; Bandini Giuseppe; Lemoli Roberto Massimo; Motta Maria Rosa; Rizzi Simonetta; Guidice Valeria; Zompatori Maurizio; Stefoni Vittorio; Alinari Lapo; Musuraca Gerardo; Marchi Enrica; Bassi Simona; Conte Roberto; Pileri Stefano; Tura Sante; Baccarani Michele
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience.
Leukemia & lymphoma 2004;45(2):321-6.
2004: Barbui Tiziano; Barosi Giovanni; Grossi Alberto; Gugliotta Luigi; Liberato Lucio N; Marchetti Monia; Mazzucconi Maria Gabriella; Rodeghiero Francesco; Tura Sante
Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2004;89(2):215-32.
2004: Arpinati Mario; Chirumbolo Gabriella; Urbini Benedetta; Bonifazi Francesca; Bandini Giuseppe; Saunthararajah Yogen; Zagnoli Alessandra; Stanzani Marta; Falcioni Sadia; Perrone Giulia; Tura Sante; Baccarani Michele; Rondelli Damiano
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):106-15.
2003: Mauro Francesca R; Zinzani Pierluigi; Zaja Francesco; Gentile Massimo; Vegna Maria Luce; Stefoni Vittorio; Marin Luciana; Fanin Renato; Baccarani Michele; Tura Sante; Mandelli Franco
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
Haematologica 2003;88(12):1348-57.
2003: Martinelli Giovanni; Ottaviani Emanuela; Buonamici Silvia; Isidori Alessandro; Borsaru Gabriela; Visani Giuseppe; Piccaluga Pier Paolo; Malagola Michele; Testoni Nicoletta; Rondoni Michela; Nucifora Giuseppina; Tura Sante; Baccarani Michele
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
Haematologica 2003;88(11):1221-8.
2003: Urbini Benedetta; Arpinati Mario; Bonifazi Francesca; Chirumbolo Gabriella; Falcioni Sadia; Stanzani Marta; Bandini Giuseppe; Motta Maria Rosa; Perrone Giulia; Giannini Benedetta; Tura Sante; Baccarani Michele; Rondelli Damiano
Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant.
Experimental hematology 2003;31(10):959-65.
2003: Soverini Simona; Cavo Michele; Cellini Claudia; Terragna Carolina; Zamagni Elena; Ruggeri Deborah; Testoni Nicoletta; Tosi Patrizia; De Vivo Antonio; Amabile Marilina; Grafone Tiziana; Ottaviani Emanuela; Giannini Barbara; Cangini Delia; Bonifazi Francesca; Neri Antonino; Fabris Sonia; Tura Sante; Baccarani Michele; Martinelli Giovanni
Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation.
Blood 2003;102(5):1588-94.
2003: Herwaldt Barbara L; Cacciò Simone; Gherlinzoni Filippo; Aspöck Horst; Slemenda Susan B; Piccaluga PierPaolo; Martinelli Giovanni; Edelhofer Renate; Hollenstein Ursula; Poletti Giovanni; Pampiglione Silvio; Löschenberger Karin; Tura Sante; Pieniazek Norman J
Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe.
Emerging infectious diseases 2003;9(8):942-8.
2003: Zinzani Pier Luigi; Tani Monica; Gabriele Annalisa; Poletti Venerino; Stefoni Vittorio; Alinari Lapo; Musuraca Gerardo; Bonifazi Francesca; Pileri Stefano; Tura Sante; Baccarani Michele
Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients.
Leukemia & lymphoma 2003;44(5):821-4.
2003: Zinzani Pier Luigi; Tani Monica; Gabriele Annalisa; Gherlinzoni Filippo; de Vivo Antonio; Ricci Paolo; Bandini Giuseppe; Lemoli Roberto Massimo; Motta Maria Rosa; Rizzi Simonetta; Giudice Valeria; Zompatori Maurizio; Stefoni Vittorio; Alinari Lapo; Musuraca Gerardo; Bassi Simona; Conte Roberto; Pileri Stefano; Tura Sante; Baccarani Michele
High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience.
Haematologica 2003;88(5):522-8.
2003: Martelli Maurizio; Gherlinzoni Filippo; De Renzo Amalia; Zinzani Pier Luigi; De Vivo Antonio; Cantonetti Maria; Falini Brunangelo; Storti Sergio; Meloni Giovanna; Rizzo Manuela; Molinari Anna Lia; Lauria Francesco; Moretti Luciano; Lauta Vito Michele; Mazza Patrizio; Guardigni Luciano; Pescarmona E; Pileri S A; Mandelli Franco; Tura Sante
Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1255-62.
2003: Zinzani Pier Luigi; Carrillo Giovanna; Ascani Stefano; Barbieri Enza; Tani Monica; Paulli Marco; Stefoni Vitttorio; Sabattini Elena; Alinari Lapo; Binazzi Roberto; Tura Sante; Baccarani Michele; Pileri Stefano A
Primary bone lymphoma: experience with 52 patients.
Haematologica 2003;88(3):280-5.
2003: Arpinati Mario; Terragna Carolina; Chirumbolo Gabriella; Rizzi Simonetta; Urbini Benedetta; Re Francesca; Tura Sante; Baccarani Michele; Rondelli Damiano
Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
Experimental hematology 2003;31(1):31-8.
2002: Alessandrino Emilio Paolo; Amadori Sergio; Barosi Giovanni; Cazzola Mario; Grossi Alberto; Liberato Lucio N; Locatelli Franco; Marchetti Monia; Morra Enrica; Rebulla Paolo; Visani Giuseppe; Tura Sante;
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
Haematologica 2002;87(12):1286-306.
2002: Soverini Simona; Terragna Carolina; Testoni Nicoletta; Ruggeri Deborah; Tosi Patrizia; Zamagni Elena; Cellini Claudia; Cavo Michele; Baccarani Michele; Tura Sante; Martinelli Giovanni
Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis.
Haematologica 2002;87(10):1036-40.
2002: Caletti G; Zinzani P L; Fusaroli P; Buscarini E; Parente F; Federici T; Peyre S; De Angelis C; Bonanno G; Togliani T; Pileri S; Tura S;
The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
Alimentary pharmacology & therapeutics 2002;16(10):1715-22.
2002: Cavo Michele; Zamagni Elena; Cellini Claudia; Tosi Patrizia; Cangini Delia; Cini Michele; Valdrè Lelia; Palareti Gualtiero; Masini Luciano; Tura Sante; Baccarani Michele
Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.
Blood 2002;100(6):2272-3.
2002: Cavo Michele; Benni Monica; Ronconi Sonia; Fiacchini Mauro; Gozzetti Alessandro; Zamagni Elena; Cellini Claudia; Tosi Patrizia; Baccarani Michele; Tura Sante;
Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
Haematologica 2002;87(9):934-42.
2002: Catani L; Vianelli N; Amabile M; Pattacini L; Valdrè L; Fagioli M E; Poli M; Gugliotta L; Moi P; Marini M G; Martinelli G; Tura S; Baccarani M
Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1773-81.
2002: Piccaluga P P; Visani G; Pileri S A; Ascani S; Grafone T; Isidori A; Malagola M; Finelli C; Martinelli G; Ricci P; Baccarani M; Tura S
Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1609-14.
2002: Ottmann Oliver G; Druker Brian J; Sawyers Charles L; Goldman John M; Reiffers Jose; Silver Richard T; Tura Sante; Fischer Thomas; Deininger Michael W; Schiffer Charles A; Baccarani Michele; Gratwohl Alois; Hochhaus Andreas; Hoelzer Dieter; Fernandes-Reese Sofia; Gathmann Insa; Capdeville Renaud; O'Brien Stephen G
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.
Blood 2002;100(6):1965-71.
2002: Zinzani P L; Gherlinzoni F; Storti S; Zaccaria A; Pavone E; Moretti L; Gentilini P; Guardigni L; De Renzo A; Fattori P P; Falini B; Lauta V M; Mannina D; Zaja F; Mazza P; Volpe E; Lauria F; Aitini E; Ciccone F; Tani M; Stefoni V; Alinari L; Baccarani M; Tura S
Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1364-9.
2002: Zinzani Pier Luigi; Tani Monica; Molinari Anna Lia; Stefoni Vittorio; Zuffa Eliana; Alinari Lapo; Gabriele Annalisa; Bonifazi Francesca; Salvucci Marzia; Tura Sante; Baccarani Michele
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Haematologica 2002;87(8):816-21.
2002: Ratta Marina; Fagnoni Francesco; Curti Antonio; Vescovini Rosanna; Sansoni Paolo; Oliviero Barbara; Fogli Miriam; Ferri Elisa; Della Cuna Gioacchino Robustelli; Tura Sante; Baccarani Michele; Lemoli Roberto M
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.
Blood 2002;100(1):230-7.
2002: Zinzani P L; Chierichetti F; Zompatori M; Tani M; Stefoni V; Garraffa G; Albertini P; Alinari L; Ferlin G; Baccarani M; Tura S
Advantages of positron emission tomography (PET) with respect to computed tomography in the follow-up of lymphoma patients with abdominal presentation.
Leukemia & lymphoma 2002;43(6):1239-43.
2002: Arpinati M; Chirumbolo G; Urbini B; Martelli V; Stanzani M; Falcioni S; Bonifazi F; Bandini G; Tura S; Baccarani M; Rondelli D
Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2002;29(11):887-91.
2002: Tosi Patrizia; Zamagni Elena; Cellini Claudia; Ronconi Sonia; Patriarca Francesca; Ballerini Filippo; Musto Pellegrino; Di Raimondo Francesco; Ledda Antonio; Lauria Francesco; Masini Luciano; Gobbi Marco; Vacca Angelo; Ria Roberto; Cangini Delia; Tura Sante; Baccarani Michele; Cavo Michele
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.
Haematologica 2002;87(4):408-14.
2002: Curti Antonio; Tafuri Agostino; Ricciardi Maria R; Tazzari Pierluigi; Petrucci Maria T; Fogli Miriam; Ratta Marina; Lapalombella Rosa; Ferri Elisa; Tura Sante; Baccarani Michele; Lemoli Roberto M
Interleukin-11 induces proliferation of human T-cells and its activity is associated with downregulation of p27(kip1).
Haematologica 2002;87(4):373-80.
2002: Poletti Venerino; Trisolini Rocco; Tura Sante
Pulmonary disease in patients with hematologic malignancies.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2002;19(1):29-45.
2002: Talpaz Moshe; Silver Richard T; Druker Brian J; Goldman John M; Gambacorti-Passerini Carlo; Guilhot Francois; Schiffer Charles A; Fischer Thomas; Deininger Michael W N; Lennard Anne L; Hochhaus Andreas; Ottmann Oliver G; Gratwohl Alois; Baccarani Michele; Stone Richard; Tura Sante; Mahon Francois-Xavier; Fernandes-Reese Sofia; Gathmann Insa; Capdeville Renaud; Kantarjian Hagop M; Sawyers Charles L
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.
Blood 2002;99(6):1928-37.
2002: Piccaluga Pier Paolo; Visani Giuseppe; Finelli Carlo; Grafone Tiziana; Baccarani Michele; Tura Sante
Efficacy of thalidomide in the treatment of myelodysplastic syndromes.
Haematologica 2002;87(3):ELT18.
2002: Baccarani Michele; Rosti Gianantonio; de Vivo Antonio; Bonifazi Francesca; Russo Domenico; Martinelli Giovanni; Testoni Nicoletta; Amabile Marilina; Fiacchini Mauro; Montefusco Enrico; Saglio Giuseppe; Tura Sante;
A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.
Blood 2002;99(5):1527-35.
2002: Re Francesca; Arpinati Mario; Testoni Nicoletta; Ricci Paolo; Terragna Carolina; Preda Paola; Ruggeri Deborah; Senese Barbara; Chirumbolo Gabriella; Martelli Valeria; Urbini Benedetta; Baccarani Michele; Tura Sante; Rondelli Damiano
Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
Experimental hematology 2002;30(2):126-34.
2002: Rambaldi Alessandro; Lazzari Manuela; Manzoni Cristina; Carlotti Emanuela; Arcaini Luca; Baccarani Michele; Barbui Tiziano; Bernasconi Carlo; Dastoli Giuseppe; Fuga Giovanna; Gamba Enrica; Gargantini Livio; Gattei Valter; Lauria Francesco; Lazzarino Mario; Mandelli Franco; Morra Enrica; Pulsoni Alessandro; Ribersani Michela; Rossi-Ferrini Pier Luigi; Rupolo Maurizio; Tura Sante; Zagonel Vittorina; Zaja Francesco; Zinzani PierLuigi; Reato Gigliola; Foa Robin
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma.
Blood 2002;99(3):856-62.
2002: Buonamici Silvia; Ottaviani Emanuela; Testoni Nicoletta; Montefusco Vittorio; Visani Giuseppe; Bonifazi Francesca; Amabile Marilina; Terragna Carolina; Ruggeri Deborah; Piccaluga Pier Paolo; Isidori Alessandro; Malagola Michele; Baccarani Michele; Tura Sante; Martinelli Giovanni
Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
Blood 2002;99(2):443-9.
2001: Bonifazi F; de Vivo A; Rosti G; Guilhot F; Guilhot J; Trabacchi E; Hehlmann R; Hochhaus A; Shepherd P C; Steegmann J L; Kluin-Nelemans H C; Thaler J; Simonsson B; Louwagie A; Reiffers J; Mahon F X; Montefusco E; Alimena G; Hasford J; Richards S; Saglio G; Testoni N; Martinelli G; Tura S; Baccarani M;
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders.
Blood 2001;98(10):3074-81.
2001: Visani G; Buonamici S; Malagola M; Isidori A; Piccaluga P P; Martinelli G; Ottaviani E; Grafone T; Baccarani M; Tura S
Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(11):1696-700.
2001: Zinzani P L; Stefoni V; Tani M; Barbieri E; Albertini P; Vigna E; Gherlinzoni F; Alinari L; Galuppi A; Pileri S; Babini L; Tura S
MACOP-B regimen followed by involved-field radiation therapy in early-stage aggressive non-Hodgkin's lymphoma patients: 14-year update results.
Leukemia & lymphoma 2001;42(5):989-95.
2001: Martinelli G; Tosi P; Ottaviani E; Soverini S; Tura S
Molecular therapy for multiple myeloma.
Haematologica 2001;86(9):908-17.
2001: Campanini F; Santucci M A; Brusa G; Pattacini L; Arpinati M; Rondelli D; Gamberi B; Barbieri E; Babini L; Tura S
Expression of P21(WAF1/CIP1/SID1) cyclin-dependent kinase inhibitor in hematopoietic progenitor cells.
Gene 2001;273(2):173-80.
2001: Visani G; Bernasconi P; Boni M; Castoldi G L; Ciolli S; Clavio M; Cox M C; Cuneo A; Del Poeta G; Dini D; Falzetti D; Fanin R; Gobbi M; Isidori A; Leoni F; Liso V; Malagola M; Martinelli G; Mecucci C; Piccaluga P P; Petti M C; Rondelli R; Russo D; Sessarego M; Specchia G; Testoni N; Torelli G; Mandelli F; Tura S
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(6):903-9.
2001: D'Aurelio M; Merlo Pich M; Catani L; Sgarbi G L; Bovina C; Formiggini G; Parenti Castelli G; Baum H; Tura S; Lenaz G
Decreased Pasteur effect in platelets of aged individuals.
Mechanisms of ageing and development 2001;122(8):823-33.
2001: Vianelli N; Valdrè L; Fiacchini M; de Vivo A; Gugliotta L; Catani L; Lemoli R M; Poli M; Tura S
Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients.
Haematologica 2001;86(5):504-9.
2001: Curti A; Ratta M; Corinti S; Girolomoni G; Ricci F; Tazzari P; Siena M; Grande A; Fogli M; Tura S; Lemoli R M
Interleukin-11 induces Th2 polarization of human CD4(+) T cells.
Blood 2001;97(9):2758-63.
2001: Visani G; Lemoli R M; Isidori A; Piccaluga P P; Martinelli G; Malagola M; Gugliotta L; Bonini A; Bonifazi F; Motta M R; Rizzi S; Castellani S; Tura S
Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients.
Bone marrow transplantation 2001;27(8):829-35.
2001: Tosi P; Ronconi S; Zamagni E; Cellini C; Grafone T; Cangini D; Pileri S A; Baccarani M; Tura S; Cavo M
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation.
Haematologica 2001;86(4):409-13.
2001: Trisolini R; Stanzani M; Agli L L; Colangelo A; Bonifazi F; Falcioni S; Patelli M; Falcone F; Bandini G; Tura S; Poletti V
Delayed non-infectious lung disease in allogeneic bone marrow transplant recipients.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2001;18(1):75-84.
2001: Zinzani P L; Tani M; Stefoni V; Albertini P; Bendandi M; Gherlinzoni F; Alinari L; Vigna E; Tura S
Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma.
Haematologica 2001;86(3):287-90.
2001: Amabile M; Giannini B; Testoni N; Montefusco V; Rosti G; Zardini C; Terragna C; Buonamici S; Ottaviani E; Soverini S; Fiacchini M; Bassi S; de Vivo A; Trabacchi E; Saglio G; Pane F; Baccarani M; Tura S; Martinelli G
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.
Haematologica 2001;86(3):252-9.
2001: Zinzani P L; Martelli M; Bendandi M; De Renzo A; Zaccaria A; Pavone E; Bocchia M; Falini B; Gobbi M; Gherlinzoni F; Stefoni V; Tani M; Tura S
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
Haematologica 2001;86(2):187-91.
2001: Campanini F; Santucci M A; Pattachini L; Brusa G; Piccioli M; Barbieri E; Babini L; Tura S
Competitive polymerase chain reaction as a method to detect the amplification of bcr-abl gene of chronic myeloid leukemia.
Haematologica 2001;86(2):167-73.
2001: Curti A; Fogli M; Ratta M; Biasco G; Tura S; Lemoli R M
Dendritic cell differentiation from hematopoietic CD34+ progenitor cells.
Journal of biological regulators and homeostatic agents 2001;15(1):49-52.
2001: Curti A; Fogli M; Ratta M; Tura S; Lemoli R M
Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(2):848-54.
2001: Tosi P; Tura S
Antiangiogenic therapy in multiple myeloma.
Acta haematologica 2001;106(4):208-13.
2001: Catani L; Amabile M; Luatti S; Valdrè L; Vianelli N; Martinelli G; Tura S
Interleukin-4 downregulates nuclear factor-erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines.
Stem cells (Dayton, Ohio) 2001;19(4):339-47.
2000: Rondelli D; Re F; Bandini G; Raspadori D; Arpinati M; Senese B; Stanzani M; Bonifazi F; Falcioni S; Chirumbolo G; Tura S
Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
Bone marrow transplantation 2000;26(12):1325-31.
2000: Bocchia M; Bronte V; Colombo M P; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli R M; Massaia M; Rondelli D; Zanon P; Tura S
Antitumor vaccination: where we stand.
Haematologica 2000;85(11):1172-206.
2000: Zinzani P L; Bendandi M; Magagnoli M; Albertini P; Rondelli D; Stefoni V; Tani M; Tura S
Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia.
Haematologica 2000;85(11):1135-9.
2000: Tassi C; Tazzari P L; Lemoli R M; Ricci F; Tura S; Conte R
Kinetics variation of CD34+ and CD34+CD90+ in subjects following different mobilizing protocols.
Haematologica 2000;85(10):1118-20.
2000: Martinelli G; Terragna C; Zamagni E; Ronconi S; Tosi P; Lemoli R; Bandini G; Testoni N; Amabile M; Ottaviani E; Buonamici S; Soverini S; Montefusco V; de Vivo A; Bonifazi F; Tura S; Cavo M
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation.
Haematologica 2000;85(9):930-4.
2000: Zinzani P L; Bendandi M; Stefoni V; Albertini P; Gherlinzoni F; Tani M; Piccaluga P P; Tura S
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patients.
Haematologica 2000;85(9):926-9.
2000: Zinzani P L; Magagnoli M; Bendandi M; Tani M; Stefoni V; Cellini C; Poggi S; Piccioli M; Pileri S; Tura S
Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
Haematologica 2000;85(9):922-5.
2000: Martinelli G; Montefusco V; Amabile M; Lemoli R M; Terragna C; Testoni N; Ottaviani E; Rosti G; de Vivo A; Rizzi S; Russo D; Bregoli M; Tura S
Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response.
Leukemia & lymphoma 2000;39(1-2):113-20.
2000: Ratta M; Curti A; Fogli M; Pantucci M; Viscomi G; Tazzari P; Fagnoni F; Vescovini R; Sansoni P; Tura S; Lemoli R M
Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Experimental hematology 2000;28(8):931-40.
2000: Tosi P; Zamagni E; Ronconi S; Benni M; Motta M R; Rizzi S; Tura S; Cavo M
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(7):1310-3.
2000: Fogli M; Carlo-Stella C; Curti A; Ratta M; Tazzari P L; Ragazzi E; Colla S; Santucci A M; Tura S; Lemoli R M
Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis.
Experimental hematology 2000;28(7):775-83.
2000: Zinzani P L; Magagnoli M; Bendandi M; Barbieri E; Galuppi A; Gherlinzoni F; Tani M; Albertini P; Stefoni V; Babini L; Tura S
Efficacy of the VBM regimen in the treatment of elderly patients with Hodgkin's disease.
Haematologica 2000;85(7):729-32.
2000: Zinzani P L; Baliva G; Magagnoli M; Bendandi M; Modugno G; Gherlinzoni F; Orcioni G F; Ascani S; Simoni R; Pileri S A; Tura S
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2603-6.
2000: Cavo M; Terragna C; Martinelli G; Ronconi S; Zamagni E; Tosi P; Lemoli R M; Benni M; Pagliani G; Bandini G; Tura S
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma.
Blood 2000;96(1):355-7.
2000: Visani G; Rosti G; Bandini G; Tosi P; Isidori A; Malagola M; Stanzani M; Martinelli G; Piccaluga P; Testoni N; Ricci P; Tura S
Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia.
British journal of haematology 2000;109(4):722-8.
2000: Martinelli G; Montefusco V; Testoni N; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazi F; Rosti G; Bandini G; Tura S
Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
Haematologica 2000;85(6):653-8.
2000: Martinelli G; Terragna C; Zamagni E; Ronconi S; Tosi P; Lemoli R M; Bandini G; Motta M R; Testoni N; Amabile M; Ottaviani E; Vianelli N; de Vivo A; Gozzetti A; Tura S; Cavo M
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2273-81.
2000: Visani G; Pagano L; Pulsoni A; Tosi P; Piccaluga P P; Pastano R; Grafone T; Malagola M; Isidori A; Tura S
Chemotherapy of secondary leukemias.
Leukemia & lymphoma 2000;37(5-6):543-9.
2000: Martinelli G; Ottaviani E; Testoni N; Montefusco V; Pastano R; Tura S
Long-term disease-free acute myeloblastic leukemia with inv(16) is associated with PCR undetectable CBFbeta/MYH11 transcript.
Haematologica 2000;85(5):552-5.
2000: Martinelli G; Testoni N; Amabile M; Bonifazi F; De Vivo A; Farabegoli P; Terragna C; Montefusco V; Ottaviani E; Saglio G; Russo D; Baccarani M; Rosti G; Tura S
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
Bone marrow transplantation 2000;25(7):729-36.
2000: Lemoli R M; Martinelli G; Zamagni E; Motta M R; Rizzi S; Terragna C; Rondelli R; Ronconi S; Curti A; Bonifazi F; Tura S; Cavo M
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy.
Blood 2000;95(7):2234-9.
2000: Visani G; Gugliotta L; Tosi P; Catani L; Vianelli N; Martinelli G; Ottaviani E; Testoni N; Nocentini F; Pastano R; Piccaluga P; Isidori A; Grafone T; Tura S
All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia.
European journal of haematology 2000;64(3):139-44.
2000: Zinzani P L; Magagnoli M; Bendandi M; Gherlinzoni F; Orcioni G F; Cellini C; Stefoni V; Pileri S A; Tura S
Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):363-5.
2000: Vianelli N; Renga M; Azzi A; De Santis R D; Bandini G; Tosi P; Tura S
Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation.
Bone marrow transplantation 2000;25(3):319-20.
2000: Zinzani P L; Magagnoli M; Moretti L; De Renzo A; Battista R; Zaccaria A; Guardigni L; Mazza P; Marra R; Ronconi F; Lauta V M; Bendandi M; Gherlinzoni F; Gentilini P; Ciccone F; Cellini C; Stefoni V; Ricciuti F; Gobbi M; Tura S
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):773-9.
2000: Visani G; Martinelli G; Piccaluga P; Tosi P; Amabile M; Pastano R; Cavo M; Isidori A; Tura S
Alpha-interferon improves survival and remission duration in P-190BCR-ABL positive adult acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(1):22-7.
2000: Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
Haematologica 2000;85(1):40-6.
1999: Catani L; Vianelli N; Luatti S; Rizzi S; Castellani S; Valdrè L; Lemoli R M; Tura S
Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets.
Bone marrow transplantation 1999;24(11):1191-4.
1999: Bordignon C; Carlo-Stella C; Colombo M P; De Vincentiis A; Lanata L; Lemoli R M; Locatelli F; Olivieri A; Rondelli D; Zanon P; Tura S
Cell therapy: achievements and perspectives.
Haematologica 1999;84(12):1110-49.
1999: Lemoli R M; Martinelli G; Olivieri A; Motta M R; Rizzi S; Terragna C; Leopardi G; Benni M; Ronconi S; Cantori I; Rondelli D; Mangianti S; Leoni P; Montanari M; Cavo M; Tura S
Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study.
British journal of haematology 1999;107(2):419-28.
1999: Zinzani P L; Magagnoli M; Moretti L; Battista R; Ronconi F; De Renzo A; Zaccaria A; Gentilini P; Guardigni L; Gherlinzoni F; Cellini C; Fattori P P; Bendandi M; Bocchia M; Aitini E; Tura S
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients.
Haematologica 1999;84(11):1002-6.
1999: Zinzani P L; Martelli M; Magagnoli M; Zaja F; Storti S; Pavone E; Lauta V M; De Renzo A; Gobbi M; Bocchia M; Ronconi F; Scaramucci L; Gherlinzoni F; Palombi F; Bendandi M; Stefoni V; Anticoli Borza P; Cellini C; Mandelli F; Tura S
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Haematologica 1999;84(11):996-1001.
1999: Zinzani P L; Martelli M; Magagnoli M; Pescarmona E; Scaramucci L; Palombi F; Bendandi M; Martelli M P; Ascani S; Orcioni G F; Pileri S A; Mandelli F; Tura S
Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients.
Blood 1999;94(10):3289-93.
1999: Zinzani P L; Magagnoli M; Chierichetti F; Zompatori M; Garraffa G; Bendandi M; Gherlinzoni F; Cellini C; Stefoni V; Ferlin G; Tura S
The role of positron emission tomography (PET) in the management of lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(10):1181-4.
1999: Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Trabacchi E; Saglio G; Tura S
Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2)
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(10):1635-7.
1999: Rondelli D; Lemoli R M; Ratta M; Fogli M; Re F; Curti A; Arpinati M; Tura S
Rapid induction of CD40 on a subset of granulocyte colony-stimulating factor-mobilized CD34(+) blood cells identifies myeloid committed progenitors and permits selection of nonimmunogenic CD40(-) progenitor cells.
Blood 1999;94(7):2293-300.
1999: Martinelli G; Ottaviani E; Testoni N; Visani G; Terragna C; Amabile M; Trabacchi E; Montefusco V; Tura S
Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures.
Bone marrow transplantation 1999;24(6):694-7.
1999: Rondelli D; Bandini G; Cavo M; Re F; Motta M; Senese B; Leopardi G; Stanzani M; Tura S
Discrepancy between serological complete remission and concomitant new bone lytic lesions after infusion of escalating low doses of donor lymphocytes in multiple myeloma: a case report.
Bone marrow transplantation 1999;24(6):685-7.
1999: Visani G; Ottaviani E; Zauli G; Tosi P; Pellacani A; Isidori A; Pierpaoli S; Tura S
All-trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines.
European journal of haematology 1999;63(3):149-53.
1999: Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Bone marrow transplantation 1999;24(5):467-72.
1999: Tosi P; Pellacani A; Zinzani P L; Magagnoli M; Visani G; Tura S
In vitro study of the combination gemcitabine + fludarabine on freshly isolated chronic lymphocytic leukemia cells.
Haematologica 1999;84(9):794-8.
1999: Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S
A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
Haematologica 1999;84(8):707-15.
1999: Testoni N; Borsaru G; Martinelli G; Carboni C; Ruggeri D; Ottaviani E; Pelliconi S; Ricci P; Pastano R; Visani G; Zaccaria A; Tura S
3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features.
Haematologica 1999;84(8):690-4.
1999: Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
Cancer research 1999;59(15):3803-11.
1999: Tafuri A; Lemoli R M; Petrucci M T; Ricciardi M R; Fogli M; Bonsi L; Ariola C; Strippoli P; Gregorj C; Petti M C; Tura S; Mandelli F; Bagnara G P
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells.
Experimental hematology 1999;27(8):1255-63.
1999: Zinzani P L; Magagnoli M; Franchi R; Zompatori M; Frezza G; Galassi R; Gherlinzoni F; Bendandi M; Albertini P; Monetti N; Tura S
Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement.
Haematologica 1999;84(7):604-7.
1999: Zinzani P L; Corneli G; Cancellieri A; Magagnoli M; Lacava N; Gherlinzoni F; Bendandi M; Albertini P; Baruzzi G; Tura S; Boaron M
Core needle biopsy is effective in the initial diagnosis of mediastinal lymphoma.
Haematologica 1999;84(7):600-3.
1999: Zinzani P L; Storti S; Zaccaria A; Moretti L; Magagnoli M; Pavone E; Gentilini P; Guardigni L; Gobbi M; Fattori P P; Falini B; Lauta V M; Bendandi M; Gherlinzoni F; De Renzo A; Zaja F; Mazza P; Volpe E; Bocchia M; Aitini E; Tabanelli M; Leone G; Tura S
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.
Blood 1999;94(1):33-8.
1999: Visani G; Lemoli R M; Tosi P; Martinelli G; Testoni N; Ricci P; Piccaluga P P; Pastano R; Leopardi G; Dizdari A; Motta M R; Rizzi S; Tura S
Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients.
British journal of haematology 1999;105(3):775-9.
1999: Martinelli G; Terragna C; Lemoli R M; Cavo M; Benni M; Motta M R; Amabile M; Ottaviani E; Testoni N; de Vivo A; Tura S
Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cells.
Haematologica 1999;84(5):397-404.
1999: Zinzani P L; Magagnoli M; Galieni P; Martelli M; Poletti V; Zaja F; Molica S; Zaccaria A; Cantonetti A M; Gentilini P; Guardigni L; Gherlinzoni F; Ribersani M; Bendandi M; Albertini P; Tura S
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1254.
1999: Lemoli R M; Curti A; Tura S
Negative selection of autologous peripheral blood stem cells.
Baillière's best practice & research. Clinical haematology 1999;12(1-2):57-69.
1999: Pellacani A; Tosi P; Zinzani P L; Ottaviani E; Albertini P; Magagnoli M; Tura S
Cytotoxic combination of loxoribine with fludarabine and mafosfamide on freshly isolated B-chronic lymphocytic leukemia cells.
Leukemia & lymphoma 1999;33(1-2):147-53.
1999: Tosi P; Pellacani A; Visani G; Ottaviani E; Ronconi S; Zamagni E; Benni M; Cavo M; Tura S
In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells.
European journal of haematology 1999;62(3):143-8.
1999: Gherlinzoni F; Vianelli N; Valdrè L; Catani L; Tani M; Tura S
Recombinant human tissue plasminogen activator without heparin is effective in the treatment of hepatic veno-occlusive disease.
Haematologica 1999;84(2):191-2.
1999: Lemoli R M; Visani G; Leopardi G; Motta M R; Rizzi S; Testoni N; Curti A; Tura S
Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
Bone marrow transplantation 1999;23(3):235-41.
1999: Santucci M A; Ripalti A; di Paola M C; Mianulli A M; Iacurti E; Campanini F; Gamberi B; Tura S
Procedure for the quantitation of Gadd45 expression levels in clonal hematopoietic progenitor cells by competitive polymerase chain reaction.
Clinical biochemistry 1999;32(1):1-8.
1999: Zinzani P L; Magagnoli M; Frezza G; Prologo G; Gherlinzoni F; Bendandi M; Albertini P; Babini L; D'Alessandro R; Tura S
Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience.
Leukemia & lymphoma 1999;32(5-6):571-6.
1999: Zinzani P L; Magagnoli M; Frezza G; Barbieri E; Gherlinzoni F; Galuppi A; Bendandi M; Merla E; Albertini P; Babini L; Tura S
ABVD and radiation therapy as first-line treatment in advanced Hodgkin's disease.
Leukemia & lymphoma 1999;32(5-6):553-9.
1999: Tazzari P L; Rondelli D; Re F; Bandini G; Ricci F; Tassi C; Bonini A; Stanzani M; Laudadio M A; Babini L; Conte R; Tura S
Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantation.
European journal of haematology 1999;62(1):57-62.
1998: Lemoli R M; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Biological characterization of CD34+ cells mobilized into peripheral blood.
Bone marrow transplantation 1998;22 Suppl 5():S47-50.
1998: Vianelli N; Baravelli S; Milano V; Rizzo N; Catani L; Tura S
Percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura during pregnancy.
Haematologica 1998;83(12):1127-8.
1998: Zinzani P L; Magagnoli M; Bendandi M; Orcioni G F; Gherlinzoni F; Albertini P; Pileri S A; Tura S
Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(12):1351-3.
1998: Testoni N; Lemoli R M; Martinelli G; Carboni C; Pelliconi S; Ottaviani E; Ruggeri D; Rizzi S; Motta M R; Visani G; Tura S
Autologous peripheral blood stem cell transplantation in acute myeloblastic leukaemia and myelodysplastic syndrome patients: evaluation of tumour cell contamination of leukaphereses by cytogenetic and molecular methods.
Bone marrow transplantation 1998;22(11):1065-70.
1998: Zinzani P L; Colecchia A; Festi D; Magagnoli M; Larocca A; Ascani S; Bendandi M; Orcioni G F; Gherlinzoni F; Albertini P; Pileri S A; Roda E; Tura S
Ultrasound-guided core-needle biopsy is effective in the initial diagnosis of lymphoma patients.
Haematologica 1998;83(11):989-92.
1998: Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
Haematologica 1998;83(11):985-8.
1998: Rondelli D; Raspadori D; Anasetti C; Bandini G; Re F; Arpinati M; Stanzani M; Morelli A; Baccini C; Zaccaria A; Lemoli R M; Tura S
Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells.
Bone marrow transplantation 1998;22(7):631-7.
1998: Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli R M; Olivieri A; Siena S; Zanon P; Tura S
Ex vivo expansion of hematopoietic cells and their clinical use.
Haematologica 1998;83(9):824-48.
1998: Vianelli N; Tazzari P L; Baravelli S; Ricci F; Valdrè L; Tura S
Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura.
Haematologica 1998;83(8):761-3.
1998: Andreone P; Zignego A L; Cursaro C; Gramenzi A; Gherlinzoni F; Fiorino S; Giannini C; Boni P; Sabattini E; Pileri S; Tura S; Bernardi M
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection.
Annals of internal medicine 1998;129(4):294-8.
1998: Zinzani P L; Martelli M; Magagnoli M; Zaccaria A; Ronconi F; Cantonetti M; Bocchia M; Marra R; Gobbi M; Falini B; Gherlinzoni F; Moretti L; De Renzo A; Mazza P; Pavone E; Sabattini E; Amendola A; Bendandi M; Pileri S A; Mandelli F; Tura S
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
Blood 1998;92(3):790-4.
1998: Martinelli G; Testoni N; Montefusco V; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazzi F; de Vivo A; Pane F; Rosti G; Tura S
Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresis.
Haematologica 1998;83(7):593-601.
1998: Cavo M; Bandini G; Benni M; Gozzetti A; Ronconi S; Rosti G; Zamagni E; Lemoli R M; Bonini A; Belardinelli A; Motta M R; Rizzi S; Tura S
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma.
Bone marrow transplantation 1998;22(1):27-32.
1998: Zinzani P L; Magagnoli M; Gherlinzoni F; Bendandi M; Albertini P; Merla E; Tura S
To what extent can indolent lymphoma be considered? Results of a long term follow-up study from a single center.
Haematologica 1998;83(6):502-7.
1998: Rondelli D; Anasetti C; Fortuna A; Ratta M; Arpinati M; Bandini G; Lemoli R M; Tura S
T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells.
Bone marrow transplantation 1998;21(12):1183-91.
1998: Ratta M; Rondelli D; Fortuna A; Curti A; Fogli M; Fagnoni F; Martinelli G; Terragna C; Tura S; Lemoli R M
Generation and functional characterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: comparison with bone marrow CD34+ cells.
British journal of haematology 1998;101(4):756-65.
1998: Bonini A; Bandini G; Rosti G; Rondelli D; Testoni N; Remiddi C; Motta M R; Rizzi S; Mangianti S; Campanini E; Zuffa E; Tura S
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase.
Bone marrow transplantation 1998;21(11):1085-9.
1998: Catani L; Gugliotta L; Motta M; Tazzari P; Baravelli S; Tura S
Effect of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on growth and differentiation of the HEL cell line.
Haematologica 1998;83(5):385-91.
1998: Fogli M; Amabile M; Martinelli G; Fortuna A; Rondelli D; Ratta M; Curti A; Tura S; Lemoli R M
Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrow.
British journal of haematology 1998;101(1):119-29.
1998: Zinzani P L; Pileri S; Bendandi M; Buzzi M; Sabattini E; Ascani S; Gherlinzoni F; Magagnoli M; Albertini P; Tura S
Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1532-7.
1998: Zuffa E; Bandini G; Bonini A; Santucci M A; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
Haematologica 1998;83(3):231-6.
1998: Tosi P; Visani G; Ottaviani E; Testoni N; Pellacani A; Tura S
Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro.
European journal of haematology 1998;60(3):161-5.
1998: Arcese W; Aversa F; Bandini G; De Vincentiis A; Falda M; Lanata L; Lemoli R M; Locatelli F; Majolino I; Zanon P; Tura S
Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow.
Haematologica 1998;83(2):159-82.
1998: Lemoli R M; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta M R; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Haematologica 1998;83(1):48-55.
1998: Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli R M; Tura S
Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
British journal of haematology 1998;100(1):207-18.
1997: Lemoli R M; Fortuna A; Raspadori D; Ventura M A; Martinelli G; Gozzetti A; Leopardi G; Ratta M; Cavo M; Tura S
Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma.
Leukemia & lymphoma 1997;26 Suppl 1():1-11.
1997: Lauria F; Raspadori D; Rondelli D; Ventura M A; Fiacchini M; Visani G; Forconi F; Tura S
High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(12):2075-8.
1997: Tosi P; Visani G; Ottaviani E; Gibellini D; Pellacani A; Tura S
Reduction of heat-shock protein-70 after prolonged treatment with retinoids: biological and clinical implications.
American journal of hematology 1997;56(3):143-50.
1997: Motta M R; Mangianti S; Rizzi S; Ratta M; Campanini E; Fortuna A; Fogli M; Tura S; Lemoli R M
Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
Experimental hematology 1997;25(12):1261-9.
1997: Zinzani P L; Magagnoli M; Ascani S; Ricci P; Poletti V; Gherlinzoni F; Frezza G; Bendandi M; Stefanetti C; Merla E; Pileri S; Tura S
Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: clinical and therapeutic features of 24 localized patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(9):883-6.
1997: Lemoli R M; Fortuna A; Tafuri A; Grande A; Amabile M; Martinelli G; Ferrari S; Tura S
Interleukin-9 in human myeloid leukemia cells.
Leukemia & lymphoma 1997;26(5-6):563-73.
1997: Zinzani P L; Bendandi M; Magagnoli M; Rondelli D; de Vivo A; Benni M; Zamagni E; Cavo M; Tura S
Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
European journal of haematology 1997;59(2):82-8.
1997: Tosi P; Zinzani P L; Pellacani A; Ottaviani E; Magagnoli M; Tura S
Loxoribine affects fludarabine activity on freshly isolated B-chronic lymphocytic leukemia cells.
Leukemia & lymphoma 1997;26(3-4):343-8.
1997: Raspadori D; Lauria F; Ventura M A; Rondelli D; Visani G; de Vivo A; Tura S
Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases.
Leukemia research 1997;21(7):603-7.
1997: Tosi P; Pellacani A; Visani G; Ottaviani E; Tura S
Adenoviral mediated gene transfer can be accomplished in human myeloid cell lines and is inhibited by all-trans retinoic acid-induced differentiation.
Haematologica 1997;82(4):387-91.
1997: Visani G; Baravelli S; Tosi P; Manfroi S; Remiddi C; Tura S
Slimming diet and the development of acute leukemia: a possible relationship? Report of three cases.
Leukemia & lymphoma 1997;26(1-2):181-3.
1997: Martinelli G; Testoni N; Farabegoli P; Zaccaria A; Amabile M; Visani G; Pelliconi S; Raspadori D; Manfroi S; Vittone A; Terragna C; Tura S
Amplification of third-complementary-determining-region (CDR-III) of heavy chain immunoglobulin gene (IgH) in one hundred adult acute leukemias.
Leukemia & lymphoma 1997;26(1-2):131-9.
1997: Zinzani P L; Pavone E; Storti S; Moretti L; Fattori P P; Guardigni L; Falini B; Gobbi M; Gentilini P; Lauta V M; Bendandi M; Gherlinzoni F; Magagnoli M; Venturi S; Aitini E; Tabanelli M; Leone G; Liso V; Tura S
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma.
Blood 1997;89(11):3974-9.
1997: Visani G; Ottaviani E; Danova M; Mangiarotti R; Tosi P; Tura S
The expression of proliferation and quiescence associated antigens in acute myeloid leukemia correlates with survival duration: analysis of 15 refractory cases.
Haematologica 1997;82(3):338-40.
1997: Zinzani P L; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
Haematologica 1997;82(3):305-8.
1997: Lauria F; Rondelli D; Zinzani P L; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura M A; Birtolo S; Forconi F; Tura S
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(5):629-32.
1997: Visani G; Russo D; Ottaviani E; Tosi P; Damiani D; Michelutti A; Manfroi S; Baccarani M; Tura S
Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(5):624-8.
1997: Zinzani P L; Bendandi M; Magagnoli M; Gherlinzoni F; Merla E; Tura S
Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):379-83.
1997: Bertolini F; de Vincentiis A; Lanata L; Lemoli R M; Maccario R; Majolino I; Ponchio L; Rondelli D; Tabilio A; Zanon P; Tura S
Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects.
Haematologica 1997;82(2):220-38.
1997: Martinelli G; Farabegoli P; Testoni N; Terragna C; Vittone A; Raspadori D; Amabile M; Tura S
Detection of clonality by heteroduplex analysis of amplified junctional region of T-cell receptor gamma in patients with T-cell acute lymphoblastic leukemias.
Haematologica 1997;82(2):161-5.
1997: Martinelli G; Trabetti E; Farabegoli P; Testoni N; Bandini G; Motta M R; Vittone A; Terragna C; Pignatti P F; Tura S
Early detection of bone marrow engraftment by amplification of hypervariable DNA regions.
Haematologica 1997;82(2):156-60.
1997: Zinzani P L; Lauria F; Salvucci M; Rondelli D; Raspadori D; Bendandi M; Magagnoli M; Tura S
Hairy-cell leukemia and alpha-interferon treatment: long-term responders.
Haematologica 1997;82(2):152-5.
1997: Lemoli R M; Tafuri A; Fortuna A; Petrucci M T; Ricciardi M R; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
Blood 1997;89(4):1189-96.
1997: Martinelli G; Vianelli N; De Vivo A; Ricci P; Remiddi C; Testoni N; Visani G; Baravelli S; Farabegoli P; Tura S
Granulocytic sarcomas: clinical, diagnostic and therapeutical aspects.
Leukemia & lymphoma 1997;24(3-4):349-53.
1997: Rondelli D; Lauria F; Zinzani P L; Raspadori D; Ventura M A; Galieni P; Birtolo S; Forconi F; Algeri R; Tura S
2-Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders.
European journal of haematology 1997;58(1):46-50.
1997: Santucci M A; Lemoli R M; Tura S
Peripheral blood mobilization of hematopoietic stem cells: cytokine-mediated regulation of adhesive interactions within the hematopoietic microenvironment.
Acta haematologica 1997;97(1-2):90-6.
1996: Testoni N; Martinelli G; Zaccaria A; Miggiano M C; Pelliconi S; Visani G; Manfroi S; Gherlinzoni F; Mangianti S; Tura S
Detection of occasional and clonal chromosome aberrations in patients with acute non-lymphocytic leukemia after autologous bone marrow transplantation.
Bone marrow transplantation 1996;18(6):1141-5.
1996: Zinzani P L; Bendandi M; Visani G; Gherlinzoni F; Frezza G; Merla E; Manfroi S; Gozzetti A; Tura S
Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients.
Leukemia & lymphoma 1996;23(5-6):577-82.
1996: Zuffa E; Vianelli N; Martinelli G; Tazzari P; Cavo M; Tura S
Autoimmune mediated thrombocytopenia associated with the use of interferon-alpha in chronic myeloid leukemia.
Haematologica 1996;81(6):533-5.
1996: Zinzani P L; Baccini C; Zaccaria A; Visani G; Buzzi M; Morelli A; Molinari A L; Salvucci M; Bendandi M; Rubboli D; Gherlinzoni F; Zanchini R; Tura S
Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma.
European journal of haematology 1996;57(5):335-40.
1996: Lemoli R M; Rosti G; Visani G; Gherlinzoni F; Miggiano M C; Fortuna A; Zinzani P; Tura S
Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3018-25.
1996: Visani G; Tosi P; Ottaviani E; Zaccaria A; Baccini C; Manfroi S; Pastano R; Remiddi C; Morelli A; Molinari A L; Zanchini R; Tura S
All-trans retinoic acid and in vitro cytokine production by acute promyelocytic leukemia cells.
European journal of haematology 1996;57(4):301-6.
1996: Tosi P; Visani G; Ottaviani E; Pellacani A; Manfroi S; Tura S
Retinoids increase idarubicin cytotoxicity in human myeloid leukemia cell lines.
Anti-cancer drugs 1996;7(7):774-9.
1996: Tosi P; Visani G; Ottaviani E; Manfroi S; Tura S
Biological and clinical significance of in vitro prednisolone resistance in adult acute lymphoblastic leukaemia.
European journal of haematology 1996;57(2):134-41.
1996: Cappio F C; Cavo M; DeVincentiis A; Lanuta L; Lemoli R M; Majolino I; Tarella C; Zanon P; Tura S
Peripheral blood stem cell transplantation for the treatment of multiple myeloma: biological and clinical implications.
Haematologica 1996;81(4):356-75.
1996: Lauria F; Raspadori D; Ventura M A; Rondelli D; Zinzani P L; Gherlinzoni F; Miggiano M C; Fiacchini M; Rosti G; Rizzi S; Tura S
Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation.
Bone marrow transplantation 1996;18(1):79-85.
1996: Martinelli G; Testoni N; Zuffa E; Visani G; Zinzani P L; Zaccaria A; Farabegoli P; Arpinati M; Amabile M; Tura S
FLANG (fludarabine + cytosine arabinoside + novantrone + G-CSF) induces partial remission in lymphoid blast transformation of Ph+chronic myelogenous leukaemia.
Leukemia & lymphoma 1996;22(1-2):173-6.
1996: Zinzani P L; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi M R; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1996;22(1-2):131-5.
1996: Visani G; Tosi P; Zinzani P L; Manfroi S; Ottaviani E; Cenacchi A; Carrara P; Clavio M; Gobbi M; Tura S
FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects.
European journal of haematology 1996;56(5):308-12.
1996: Lemoli R M; Fortuna A; Tafuri A; Fogli M; Amabile M; Grande A; Ricciardi M R; Petrucci M T; Bonsi L; Bagnara G; Visani G; Martinelli G; Ferrari S; Tura S
Interleukin-9 stimulates the proliferation of human myeloid leukemic cells.
Blood 1996;87(9):3852-9.
1996: Testoni N; Martinelli G; Farabegoli P; Zaccaria A; Amabile M; Raspadori D; Pelliconi S; Zuffa E; Carboni C; Tura S
A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients.
Blood 1996;87(9):3822-7.
1996: Martinelli G; Trabetti E; Farabegoli P; Buzzi M; Zaccaria A; Testoni N; Amabile M; Casartelli A; de Vivo A; Pignatti P F; Tura S
'Fingerprinting' of HLA-DQA by polymerase chain reaction and heteroduplex analysis.
Molecular and cellular probes 1996;10(2):123-7.
1996: Zinzani P L; Bendandi M; Frezza G; Gherlinzoni F; Merla E; Salvucci M; Magagnoli M; Babini L; Tura S
Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients.
Leukemia & lymphoma 1996;21(3-4):311-6.
1996: Tosi P; Visani G; Ottaviani E; Manfroi S; Tura S
In vitro culture with prednisolone increases BCL-2 protein expression in adult acute lymphoblastic leukemia cells.
American journal of hematology 1996;51(4):261-4.
1996: Miggiano M C; Gherlinzoni F; Rosti G; Bandini G; Visani G; Fiacchini M; Ricci P; Testoni N; Motta M R; Geromin A; Rizzi S; Belardinelli A; Mangianti S; Manfroi S; Tura S
Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(3):402-9.
1996: Zinzani P L; Bendandi M; Gherlinzoni F; Merla E; Gozzetti A; Tura S
FLU-ID (fludarabine and idarubicin) regimen as salvage therapy in pretreated low-grade non-Hodgkin's lymphoma.
Haematologica 1996;81(2):168-71.
1996: Visani G; Bontempo G; Manfroi S; Pazzaglia A; D'Alessandro R; Tura S
All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association.
Haematologica 1996;81(2):152-4.
1996: Frezza G; Barbieri E; Zinzani P L; Babini L; Tura S
Supradiaphragmatic early stage Hodgkin's disease: does mantle radiation therapy still have a role?
Haematologica 1996;81(2):138-42.
1996: Zinzani P L; Gherlinzoni F; Piovaccari G; Frezza G; Bendandi M; Ferretti R M; Barbieri E; Fiacchini M; Babini L; Magnani B; Tura S
Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients.
Haematologica 1996;81(2):132-7.
1996: Martinelli G; Farabegoli P; Buzzi M; Panzica G; Zaccaria A; Bandini G; Calori E; Testoni N; Rosti G; Conte R; Remiddi C; Salvucci M; De Vivo A; Tura S
Fingerprinting of HLA class I genes for improved selection of unrelated bone marrow donors.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1996;23(1):55-65.
1996: Catani L; Gugliotta L; Vianelli N; Nocentini F; Baravelli S; Bandini G; Cirio T M; Tura S
Endothelium and bone marrow transplantation.
Bone marrow transplantation 1996;17(2):277-80.
1996: Martelli M; Vignetti M; Zinzani P L; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli M F; Calabresi F; Tura S; Mandelli F
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):534-42.
1996: Lemoli R M; Fortuna A; Motta M R; Rizzi S; Giudice V; Nannetti A; Martinelli G; Cavo M; Amabile M; Mangianti S; Fogli M; Conte R; Tura S
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
Blood 1996;87(4):1625-34.
1996: Aglietta M; De Vincentiis A; Lanata L; Lanza F; Lemoli R M; Menichella G; Tafuri A; Zanon P; Tura S
Peripheral blood stem cells in acute myeloid leukemia: biology and clinical applications.
Haematologica 1996;81(1):77-92.
1996: Santucci M A; Saglio G; Tura S
Pathogenesis and progression of chronic myeloid leukemia.
Haematologica 1996;81(1):63-76.
1996: Vianelli N; Catani L; Gugliotta L; Nocentini F; Baravelli S; Lancellotti G; Tura S
Increased P-selectin plasma levels in patients with thrombotic thrombocytopenic purpura.
Haematologica 1996;81(1):3-7.
1996: Lemoli R M; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
Acta haematologica 1996;95(3-4):164-70.
1995: Cavo M; Benni M; Gozzetti A; Tura S
The role of haematopoietic stem cell-supported myeloablative therapy for the management of multiple myeloma.
Baillière's clinical haematology 1995;8(4):795-813.
1995: Lemoli R M; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano M C; Tura S
Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Experimental hematology 1995;23(14):1520-6.
1995: Zinzani P L; Frezza G; Bendandi M; Barbieri E; Gherlinzoni F; Neri S; Baldissera A; Salvucci M; Babini L; Tura S
Primary gastric lymphoma: a clinical and therapeutic evaluation of 82 patients.
Leukemia & lymphoma 1995;19(5-6):461-6.
1995: Visani G; Petti M C; Cenacchi A; Manfroi S; Tosi P; Spadea A; Latagliata R; Amadori S; Mandelli F; Tura S
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemia.
Leukemia & lymphoma 1995;19(5-6):447-51.
1995: Bonini A; Bandini G; Cirio T M; Tosi P; Rosti G; Tura S
Methotrexate and delayed engraftment in allogeneic bone marrow transplantation.
Bone marrow transplantation 1995;16(5):729-30.
1995: Lemoli R M; Fogli M; Fortuna A; Amabile M; Zucchini P; Grande A; Martinelli G; Visani G; Ferrari S; Tura S
Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells.
British journal of haematology 1995;91(2):319-26.
1995: Visani G; Tosi P; Manfroi S; Ottaviani E; Finelli C; Cenacchi A; Bendandi M; Tura S
All-trans retinoic acid in the treatment of myelodysplastic syndromes.
Leukemia & lymphoma 1995;19(3-4):277-80.
1995: Zinzani P L; Bendandi M; Tura S
FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma.
European journal of haematology 1995;55(4):262-6.
1995: Raspadori D; Lauria F; Ventura M A; Tazzari P L; Ferrini S; Miggiano M C; Rondelli D; Tura S
Low doses of rIL2 after autologous bone marrow transplantation induce a "prolonged" immunostimulation of NK compartment in high-grade non-Hodgkin's lymphomas.
Annals of hematology 1995;71(4):175-9.
1995: Galieni P; Cavo M; Avvisati G; Pulsoni A; Falbo R; Bonelli M A; Russo D; Petrucci M T; Bucalossi A; Tura S
Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(7):687-91.
1995: Mantovani V; Martinelli G; Bragliani M; Buzzi M; Selva P; Collina E; Farabegoli P; Rosti G A; Bandini G; Tura S
Molecular analysis of HLA genes for the selection of unrelated bone marrow donor.
Bone marrow transplantation 1995;16(3):329-35.
1995: Lauria F; Bagnara G P; Rondelli D; Raspadori D; Strippoli P; Bonsi L; Ventura M A; Montanaro L L; Bubola G; Tura S
Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia.
Leukemia & lymphoma 1995;18(5-6):451-5.
1995: Cavo M; Benni M; Cirio T M; Gozzetti A; Tura S
Allogeneic bone marrow transplantation for the treatment of multiple myeloma. An overview of published reports.
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():126-31.
1995: Lauria F; Raspadori D; Ventura M A; Rondelli D; Testoni N; Tosi P; Michieli M; Damiani D; Motta M R; Tura S
The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance.
Stem cells (Dayton, Ohio) 1995;13(4):428-34.
1995: Zinzani P L; Gherlinzoni F; Bendandi M; Zaccaria A; Aitini E; Salvucci M; Tura S
Fludarabine treatment in resistant Waldenstrom's macroglobulinemia.
European journal of haematology 1995;54(2):120-3.
1995: Bendandi M; Zaccaria A; Zinzani P L; Visani G; Stefanati V; Cantagalli F; Mancino A; Macchi S; Simoncelli F; Tura S
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease.
Leukemia & lymphoma 1995;16(5-6):511-3.
1995: Lemoli R M; Fogli M; Fortuna A; Tura S
Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor beta 3 (TGF-beta 3) on human primitive hematopoietic progenitor cells.
Haematologica 1995;80(1):5-12.
1995: Tosi P; Gherlinzoni F; Visani G; Coronado O; Chiodo F; Tura S
AZT+methotrexate in high-grade HIV-related non-Hodgkin lymphomas: interim report on feasibility and tolerance.
Haematologica 1995;80(1):31-4.
1995: Zaccaria A; Martinelli G; Testoni N; Zuffa E; Farabegoli P; Russo D; Guerrasio A; Tura S
Does the type of BCR/ABL junction predict the survival of patients with Ph1-positive chronic myeloid leukemia?
Leukemia & lymphoma 1995;16(3-4):231-6.
1994: Tosi P; Bandini G; Tazzari P; Raspadori D; Cirio T M; Rosti G; Bonini A; Conte R; Tura S
Autoimmune neutropenia after unrelated bone marrow transplantation.
Bone marrow transplantation 1994;14(6):1003-4.
1994: Lemoli R M; Fortuna A; Grande A; Gamberi B; Bonsi L; Fogli M; Amabile M; Cavo M; Ferrari S; Tura S
Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells.
British journal of haematology 1994;88(4):760-9.
1994: Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(12):2183-7.
1994: Tosi P; Visani G; Ottaviani E; Manfori S; Zinzani P L; Tura S
Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(12):2076-82.
1994: Nocentini F; Gugliotta L; Catani L; Vianelli N; Baravelli S; Martelli V; Tura S
Negligible hemostatic toxicity of intermediate-dose Erwinase in adult patients with acute lymphoblastic leukemia: preliminary data.
Haematologica 1994;79(6):546-9.
1994: Visani G; Tosi P; Cenacchi A; Manfroi S; Gamberi B; Ottaviani E; Tura S
Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia.
Leukemia & lymphoma 1994;15(1-2):143-7.
1994: Tosi P; Visani G; Gibellini D; Zauli G; Ottaviani E; Cenacchi A; Gamberi B; Manfroi S; Marchisio M; Tura S
All-trans retinoic acid and induction of apoptosis in acute promyelocytic leukemia cells.
Leukemia & lymphoma 1994;14(5-6):503-7.
1994: Zinzani P L; Gherlinzoni F; Bendandi M; Salvucci M; Tura S
Adult Burkitt's lymphoma: clinical and prognostic evaluation of 20 patients.
Leukemia & lymphoma 1994;14(5-6):465-70.
1994: Lemoli R M; Fortuna A; Fogli M; Motta M R; Rizzi S; Benini C; Tura S
Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Experimental hematology 1994;22(9):919-23.
1994: Zinzani P L; Tabanelli M; Bendandi M; Tura S
Prolonged bone marrow aplasia of refractory prolymphocytoid variant of B-cell chronic lymphocytic leukemia related to fludarabine treatment.
European journal of haematology 1994;53(1):56-8.
1994: Bandini G; Belardinelli A; Rosti G; Calori E; Motta M R; Rizzi S; Benini C; Tura S
Toxicity of high-dose busulphan and cyclophosphamide as conditioning therapy for allogeneic bone marrow transplantation in adults with haematological malignancies.
Bone marrow transplantation 1994;13(5):577-81.
1994: Tura S; Zinzani P L
New target of chronic lymphocytic leukemia treatment.
Haematologica 1994;79(3):197-8.
1994: Lauria F; Raspadori D; Ventura M A; Rondelli D; Tura S
CD7 expression does not affect the prognosis in acute myeloid leukemia.
Blood 1994;83(10):3097-8.
1994: Gugliotta L; Catani L; Vianelli N; Gherlinzoni F; Miggiano M C; Bandini G; Tura S
High plasma levels of tumor necrosis factor-alpha may be predictive of veno-occlusive disease in bone marrow transplantation.
Blood 1994;83(8):2385-6.
1994: Lemoli R M; Tazzari P L; Fortuna A; Bolognesi A; Gulati S C; Stirpe F; Tura S
Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins.
Bone marrow transplantation 1994;13(4):465-71.
1994: Zaccaria A; Testoni M; Martinelli G; Pelliconi S; Buzzi M; Farbegoli P; Naldi S; Salvucci M; Tura S
Four-chromosomes complex translocations in acute promyelocytic leukemia: description of two cases.
European journal of haematology 1994;52(3):129-33.
1994: Zinzani P L; Buzzi M; Farabegoli P; Tosi P; Fortuna A; Visani G; Martinelli G; Zaccaria A; Tura S
Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells.
Leukemia & lymphoma 1994;13(1-2):95-7.
1994: Visani G; Tosi P; Zinzani P L; Manfroi S; Zaccaria A; Testoni N; Lemoli R M; Rosti G; Pelliconi S; Tura S
FLAG (fludarabine+cytosine arabinoside+G-CSF) induces complete remission in acute-phase chronic myeloid leukaemia: a case report.
British journal of haematology 1994;86(2):394-6.
1994: Mazzucconi M G; Gugliotta L; Leone G; Dragoni F; Belmonte M M; De Stefano V; Chistolini A; Tura S; Mandelli F
Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1994;5(1):23-8.
1994: Zinzani P L; Levrero M G; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro F R; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
Haematologica 1994;79(1):55-60.
1994: Lauria F; Benfenati D; Raspadori D; Rondelli D; Ventura M A; Pileri S; Sabattini E; Poggi S; Benni M; Tura S
Retreatment with 2-CdA of progressed HCL patients.
Leukemia & lymphoma 1994;14 Suppl 1():143-5.
1993: Lemoli R M; Fogli M; Fortuna A; Motta M R; Rizzi S; Benini C; Tura S
Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Experimental hematology 1993;21(13):1668-72.
1993: Lauria F; Benfenati D; Raspadori D; Rondelli D; Zinzani P L; Tura S
High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine.
Leukemia & lymphoma 1993;11(5-6):399-404.
1993: Raspadori D; Lauria F; Ventura M A; Rondelli D; Tura S
Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activity.
Annals of hematology 1993;67(5):213-6.
1993: Zinzani P L; Bendandi M; Gherlinzoni F; Mazza P; Salvucci M; Aitini E; Miggiano M C; Gozzetti A; Tura S
VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly.
Haematologica 1993;78(6):378-82.
1993: Tosi P; Visani G; Ottaviani E; Gamberi B; Cenacchi A; Tura S
Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562.
European journal of haematology 1993;51(4):209-13.
1993: Motta M R; Benini C; Bandini G; Gherlinzoni F; Miggiano M C; Calori E; Lemoli R M; Tura S
Autologous bone marrow transplantation with marrow cryopreserved for ten years.
Bone marrow transplantation 1993;12(2):177.
1993: Finelli C; Gugliotta L; Gamberi B; Vianelli N; Visani G; Tura S
Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa.
American journal of hematology 1993;43(4):316-8.
1993: Vianelli N; Gugliotta L; Catani L; Baravelli S; Tura S
Thrombotic thrombocytopenic purpura: relapse and pregnancy.
Haematologica 1993;78(4):259.
1993: Zauli G; Gugliotta L; Catani L; Vianelli N; Borgatti P; Belmonte M M; Tura S
Increased serum levels of transforming growth factor beta-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis.
British journal of haematology 1993;84(3):381-6.
1993: Visani G; Zauli G; Tosi P; Fogli M; Cenacchi A; Finelli C; Gamberi B; Ottaviani E; Manfoi S; Tura S
Impairment of GM-CSF production in myelodysplastic syndromes.
British journal of haematology 1993;84(2):227-31.
1993: Visani G; Fogli M; Tosi P; Ottaviani E; Gamberi B; Cenacchi A; Manfroi S; Tura S
Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitors.
Annals of hematology 1993;66(6):273-6.
1993: Testoni N; Zaccaria A; Martinelli G; Pelliconi S; Buzzi M; Farabegoli P; Panzica G; Tura S
t(8;14)(q11;q32) in acute lymphoid leukemia: description of two cases.
Cancer genetics and cytogenetics 1993;67(1):55-8.
1993: Tura S; Fiacchini M; Zinzani P L; Brusamolino E; Gobbi P G
Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):925-30.
1993: Zinzani P L; Martelli M; Tura S; Mandelli F
Granulocyte colony stimulating factor (G-CSF) as adjunct therapy in relapsed-resistant high-grade non-Hodgkin's lymphoma.
Haematologica 1993;78(1):40-3.
1993: Tura S
The management of elderly patients with myeloproliferative disorders.
Hematological oncology 1993;11 Suppl 1():39-41.
1993: Martinelli G; Zaccaria A; Farabegoli P; Buzzi M; Testoni N; Bragliani M; Panzica G; Tura S
Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.
Leukemia & lymphoma 1993;11 Suppl 1():51-6.
1993: Santucci M A; Soligo D; Pileri S; Zuffa E; Testoni N; Tura S
Interferon-alpha effects on stromal compartment of normal and chronic myeloid leukemia hematopoiesis.
Leukemia & lymphoma 1993;11 Suppl 1():113-8.
1992: Lauria F; Raspadori D; Benfenati D; Rondelli D; Pallotti A; Tura S
Biological markers and minimal residual disease in hairy cell leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 4():149-51.
1992: Zinzani P L; Mazza P; Gherlinzoni F; Bocchia M; Bendandi M; Fiacchini M; Tura S
"Very late" relapses in Hodgkin's disease patients: a rare but real phenomenon.
Haematologica 1992;77(5):435-7.
1992: Zinzani P L; Lauria F; Raspadori D; Rondelli D; Benfenati D; Pileri S; Sabattini E; Tura S
Results in hairy-cell leukemia patients treated with alpha-interferon: predictive prognostic factors.
European journal of haematology 1992;49(3):133-7.
1992: Santucci M A; Trabetti E; Martinelli G; Buzzi M; Zaccaria A; Pileri S; Farabegoli P; Sabattini E; Tura S; Pignatti P F
Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia.
Bone marrow transplantation 1992;10(3):255-9.
1992: Catani L; Gugliotta L; Zauli G; Bagnara G P; Antonelli G; Belmonte M M; Vianelli N; Bonsi L; Brunelli M A; Tura S
In vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia.
Haematologica 1992;77(4):318-21.
1992: Rosti G; Bandini G; Belardinelli A; Calori E; Tura S; Gherlinzoni F; Miggiano C
Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation.
Lancet 1992;339(8807):1481-2.
1992: Lauria F; Rondelli D; Raspadori D; Zinzani P L; Benfenati D; Pileri S; Sabattini E; Tura S
Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment.
Leukemia & lymphoma 1992;7(1-2):103-7.
1992: Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Haematologica 1992;77(2):142-5.
1992: Vianelli N; Gugliotta L; Gianni L; Belmonte M M; Catani L; Tura S
Ascorbic acid for the treatment of chronic refractory idiopathic thrombocytopenic purpura (ITP).
Haematologica 1992;77(1):92-3.
1992: Zaccaria A; Martinelli G; Buzzi M; Zuffa E; Zamagni M D; Testoni N; Russo D; Guerrasio A; Saglio G; Tura S
M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia.
Haematologica 1992;77(1):16-20.
1991: Visani G; Damiani D; Cenacchi A; Russo D; Revignas G; Gamberi B; Fanin R; Fogli M; Baccarani M; Tura S
Granulocyte-macrophage colony-stimulating factor in acute non-lymphocytic leukemia before and after chemotherapy.
Annals of hematology 1991;63(5):276-81.
1991: Santucci M A; Zaccaria A; Testoni N; Russo D; Zuffa E; Baccarani M; Tura S
Long-term culture of chronic myeloid leukemia (CML) bone marrow cells.
Haematologica 1991;76(5):357-62.
1991: Zinzani P L; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
Haematologica 1991;76(4):305-10.
1991: Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani P L
Hodgkin's disease: controversies and challenges for the future.
Haematologica 1991;76(4):263-79.
1991: Gugliotta L; Catani L; Vianelli N; Mattioli Belmonte M; Cascione M L; Bendani M; Fanin R; Michieli M G; Baccarani M; Tura S
[Essential thrombocythemia: therapy with alpha interferons]
Haematologica 1991;76 Suppl 3():374-7.
1991: Bagnara G P; Vitale L; Zauli G; Valvassori L; Bonsi L; Strippoli P; Pastano R; Catani L; Gugliotta L; Tura S
[Essential thrombocythemia: in vitro study of megakaryocytopoiesis]
Haematologica 1991;76 Suppl 3():358-60.
1991: Tura S
[Thrombocythemia. General considerations]
Haematologica 1991;76 Suppl 3():357.
1991: Tura S; Visani G; Gamberi B
[Autologous bone marrow transplantation in acute lymphoblastic leukemia]
Haematologica 1991;76 Suppl 3():327-36.
1991: Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione M L; Belardinelli A R; Mottola L; Tura S
A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
Haematologica 1991;76(3):209-14.
1991: Zaccaria A; Tassinari A; Guerrasio A; Rosso C; Lo Coco F; Diverio D; Testoni N; Celso B; Buzzi M; Tura S
Molecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemia.
Haematologica 1991;76(3):183-7.
1991: Cimino G; Papa G; Tura S; Mazza P; Rossi Ferrini P L; Bosi A; Amadori S; Lo Coco F; D'Arcangelo E; Giannarelli D
Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(3):432-7.
1991: Fasola G; Lo Greco P; Calori E; Zilli M; Verlicchi F; Motta M R; Ricci P; Baccarani M; Tura S
Pharmacokinetics of high-dose cyclophosphamide for bone marrow transplantation.
Haematologica 1991;76(2):120-5.
1991: Catani L; Gugliotta L; Cascione M L; Mattioli Belmonte M; Vianelli N; Belardinelli A R; Tura S
Platelet function and interferon alpha-2a treatment in essential thrombocythaemia.
European journal of haematology 1991;46(3):158-62.
1991: Zinzani P L; Mazza P; Gherlinzoni F; Zanchini R; Bocchia M; Tura S
Mycosis fungoides: a therapeutical review.
Haematologica 1991;76(2):150-61.
1991: Testoni N; Zaccaria A; Celso B; Tura S
Unfavourable outcome of a patient with M2 acute non lymphocytic leukemia and a 47,XY,t(5;7)(q34;q21), +8 karyotype.
Haematologica 1991;76(1):65-8.
1991: Gherlinzoni F; Mazza P; Bocchia M; Zinzani P L; Fiacchini M; Zanchini R; Pileri S; Tura S
Stage I high-grade non-Hodgkin's lymphomas: a retrospective analysis.
Haematologica 1991;76(1):38-42.
1991: Mazza P; Bocchia M; Zanchini R; Gherlinzoni F; Zinzani P L; Pileri S; Tura S
MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B?
Haematologica 1991;76(1):47-52.
1991: Zaccaria A; Rosti G; Testoni N; Santucci M A; Tassinari A; Celso B; Buzzi M; Miggiano M C; Tura S
Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia.
Leukemia research 1991;15(5):289-96.
1991: Zinzani P L; Lauria F; Raspadori D; Buzzi M; Benfenati D; Bocchia M; Rondelli D; Tura S
Comparison of low-dose versus standard-dose alpha-interferon regimen in the hairy cell leukemia treatment.
Acta haematologica 1991;85(1):16-9.
1991: Cavo M; Tura S; Rosti G; Grimaldi M; Bandini G; Bonelli M A; Calori E; Rizzi S; Van Lint M T; Bacigalupo A
Allogenic BMT for multiple myeloma (MM). The Italian experience.
Bone marrow transplantation 1991;7 Suppl 2():31.
1991: Santucci M A; Zuffa E; Russo D; Testoni N; Buzzi M; Baccarani M; Tura S
Effects of alpha-IFN on chronic myeloid leukemia (CML) hematopoiesis maintained in long-term cultures.
Bone marrow transplantation 1991;7 Suppl 2():25.
1991: Rosti G; Zaccaria A; Testoni N; Celso B; Miggiano C; Tura S; Sessarego M; Marmont A M; Gualandi F; Francesco F
Cytogenetic follow-up after allogeneic bone marrow transplantation for Ph+ CML: update of the European Cooperative Study.
Bone marrow transplantation 1991;7 Suppl 2():19.
1991: Tura S; Mandelli F; Mazza P; Pileri S; Gherlinzoni F; Bocchia M; Zinzani P L; Fiacchini M; Martelli M; Papa G
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5 Suppl 1():74-8.
1990: Zinzani P L; Mazza P; Gherlinzoni F; Zanchini R; Bocchia M; Aitini E; Cavazzini G; Amurri B; Gobbi M; Tura S
CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.
Tumori 1990;76(6):533-6.
1990: Gherlinzoni F; Guglielmi C; Mazza P; Amadori S; Mandelli F; Tura S
Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology.
Seminars in oncology 1990;17(6 Suppl 10):3-8; discussion 8-9.
1990: Verlicchi F; Boschi S; Visani G; Guidi A; Tosi P; Cavo M; Tura S
Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119).
Blut 1990;61(5):311-3.
1990: Visani G; Rizzi S; Tosi P; Cenacchi A; Gamberi B; Lemoli R M; Papadopulu P; Tura S
In vitro effects of bisantrene on fresh clonogenic leukemia cells: a preliminary study on 15 cases.
Haematologica 1990;75(6):527-31.
1990: Rosti G; Bandini G; Miggiano M C; Albertazzi L; Ricci P; Verlicchi F; Pileri S; Tura S
An unusual case of Candida tropicalis sepsis in a patient submitted to allogeneic bone marrow transplantation.
Haematologica 1990;75(5):480-1.
1990: Lauria F; Raspadori D; Foa R; Zinzani P L; Buzzi M; Gugliotta L; Macchi S; Tura S
Reduced hematologic response to alpha-interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotype.
Cancer 1990;65(10):2233-6.
1990: Gugliotta L; D'Angelo A; Mattioli Belmonte M; Viganò-D'Angelo S; Colombo G; Catani L; Gianni L; Lauria F; Tura S
Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivo.
British journal of haematology 1990;74(4):465-70.
1990: Gherlinzoni F; Mazza P; Zinzani P L; Tura S; Lanza F; Castoldi G; Bellesi G; Rossi Ferrini P L; Mangoni L; Rizzoli V
Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas.
Blut 1990;60(3):172-6.
1990: Verlicchi F; Ricci P; Bassi A; Benfenati D; Bandini G; Rosti G; Calori E; Borghi C; Tura S
Systemic broad-spectrum antimicrobial prophylaxis in hematological patients after intensive antineoplastic chemotherapy.
Haematologica 1990;75(1):91-3.
1990: Zinzani P L; Lauria F; Buzzi M; Raspadori D; Gugliotta L; Bocchia M; Macchi S; Algeri R; Tura S
Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases.
Haematologica 1990;75(1):54-7.
1990: Lauria F; Zinzani P L; Raspadori D; Foà R; Buzzi M; Gugliotta L; Bocchia M; Benfenati D; Tura S
Relationship between immunological phenotype and hematological response to alpha-IFN treatment in 35 patients with hairy cell leukemia.
European journal of haematology. Supplementum 1990;52():3-6.
1990: Mazza P; Tura S; Bocchia M; Zinzani P L; Gherlinzoni F; Mandelli F; Anselmo M P; Papa G; Antimi M; Gobbi P G
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspective.
European journal of haematology. Supplementum 1990;52():22-4.
1989: Rosti G; Zaccaria A; Testoni N; Celso B; Bandini G; Tassinari A; Albertazzi L; Miggiano C; Tura S; Sessarego M
Cytogenetic monitoring in CML patients treated with BMT.
Bone marrow transplantation 1989;4 Suppl 4():95-7.
1989: Arcese W; Mandelli F; Papa G; Bacigalupo A; Van Lint M T; Lucarelli G; Galimberti P; Polchi P; Tura S; Bandini G
Italian survey on allogeneic BMT for chronic myeloid leukaemia.
Bone marrow transplantation 1989;4 Suppl 4():90-1.
1989: Tura S; Cavo M; Rosti G; Bandini G; Gobbi M; Grimaldi M; Miggiano M C; Albertazzi L; Bonelli M A
Allogeneic bone marrow transplantation for multiple myeloma.
Bone marrow transplantation 1989;4 Suppl 4():106-8.
1989: Bandini G; Rosti G; Cavo M; Albertazzi L; Tura S
Acceleration of autologous hematopoietic recovery by GM-CSF after allograft rejection.
Haematologica 1989;74(6):627-8.
1989: Testoni N; Zaccaria A; Celso B; Tassinari A; Rosti G; Tura S
5q- and t(2;11) in a patient with M2 acute non-lymphocytic leukemia. Case report.
Haematologica 1989;74(6):595-9.
1989: Tosi P; Visani G; Colombini R; Verlicchi F; Benfenati D; Cenacchi A; Russo D; Zuffa E; Papadopulu P; Tura S
Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL).
Haematologica 1989;74(6):555-8.
1989: Zaccaria A; Testoni N; Tassinari A; Celso B; Rassool F; Saglio G; Guerrasio A; Rosti G; Tura S
Cytogenetic and molecular studies in patients with chronic myeloid leukemia and variant Philadelphia translocations.
Cancer genetics and cytogenetics 1989;42(2):191-201.
1989: Cavo M; Galieni P; Zuffa E; Baccarani M; Gobbi M; Tura S
Prognostic variables and clinical staging in multiple myeloma.
Blood 1989;74(5):1774-80.
1989: Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi A R; Gamberi B; Lemoli R M; Tura S
[GM-CSF: its use in onco-hematologic diseases]
Haematologica 1989;74(5 Suppl):501-10.
1989: Gugliotta L; Vianelli N; Catani L; Belmonte M M; Gianni L; Cascione M L; Tura S
[Physiopathology, clinical features and therapy of thrombocytopenia]
Haematologica 1989;74(5 Suppl):168-78.
1989: Dinota A; Barbieri L; Gobbi M; Tazzari P L; Rizzi S; Bontadini A; Bolognesi A; Tura S; Stirpe F
An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.
British journal of cancer 1989;60(3):315-9.
1989: Lemoli R M; Visani G; Gobbi M; Rizzi S; Dinota A; Tassi C; Tosi P; Galieni P; Cavo M; Tura S
Normal myeloid progenitors (CFU-GM) in multiple myeloma: a preliminary study in view of autologous BMT.
Bone marrow transplantation 1989;4(4):373-7.
1989: Gugliotta L; Bagnara G P; Catani L; Gaggioli L; Guarini A; Zauli G; Belmonte M M; Lauria F; Macchi S; Tura S
In vivo and in vitro inhibitory effect of alpha-interferon on megakaryocyte colony growth in essential thrombocythaemia.
British journal of haematology 1989;71(2):177-81.
1989: Lemoli R M; Gobbi M; Tazzari P L; Tassi T C; Dinota A; Visani G; Grassi G; Mazza P; Cavo M; Tura S
Bone marrow purging for multiple myeloma by avidin-biotin immunoadsorption.
Transplantation 1989;47(2):385-7.
1989: Lauria F; Foà R; Raspadori D; Pileri S; Tassinari A; Buzzi M; Zaccaria A; Zinzani P L; Tura S
Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFN.
Bone marrow transplantation 1989;4 Suppl 1():176-8.
1989: Tura S; Visani G
Long term survivors in adult acute lymphoblastic leukemia.
Bone marrow transplantation 1989;4 Suppl 1():104-5.
1989: Tura S; Mazza P; Gherlinzoni F; Zinzani P L; Poletti G; Visani G; Lemoli R M; Cavo M; Galieni P; Tassi C
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.
Cancer chemotherapy and pharmacology 1989;23(2):123-5.
1989: Cavo M; Galieni P; Grimaldi M; Zuffa E; Bonelli M A; Gobbi M; Tura S
Improvement of Durie & Salmon staging for multiple myeloma by adding platelet count as a stratifying variable: a multivariate regression analysis of 163 untreated patients.
European journal of haematology. Supplementum 1989;51():99-104.
1989: Tura S; Cavo M; Gobbi M; Rosti G; Bandini G; Miggiano C; Albertazzi L; Grimaldi M; Visani G
High-dose chemoradiotherapy and allogenic bone marrow transplantation in multiple myeloma.
European journal of haematology. Supplementum 1989;51():191-5.
1988: Dinota A; Gobbi M; Tazzari P L; Raspadori D; Bontadini A; Lauria F; Foà R; Tura S
A sensitive test for the detection of NK activity. Plasma clot clonogenic assay.
Journal of immunological methods 1988;114(1-2):53-9.
1988: Tura S; Mazza P; Gherlinzoni F; Zinzani P L; Poletti G; Visani G; Lemoli R M; Bandini G; Cavo M; Galieni P
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies.
Haematologica 1988;73(6):503-8.
1988: Russo D; Zuffa E; Motta M R; Santucci M A; Fanin R; Testoni N; Celso B; Visani G; Baccarani M; Tura S
Low-dose interferon-alpha in Ph+ chronic myeloid leukemia: clinical cytogenetic and cell culture study.
Haematologica 1988;73(6):499-502.
1988: Tazzari P L; Gobbi M; Tassi C; Lemoli R M; Dinota A; Visani G; Tura S
In situ staining of bromodeoxyuridine positive cells in normal and neoplastic colony-forming units grown on plasma clots.
Journal of immunological methods 1988;113(2):215-9.
1988: Visani G; Lemoli R M; Dinota A; Cavo M; Gobbi M; Tura S
Improvement of human myeloma stem cell growth in a liquid culture system supplemented with phytohemagglutinin.
International journal of cell cloning 1988;6(5):313-23.
1988: Mazza P; Poletti G; Zinzani P L; Gherlinzoni F; Miniaci G; Tonielli E; Sciascia R; Tura S
Critical value of laparotomy with splenectomy in stage III Hodgkin's disease as restaging procedure after chemotherapy.
European journal of haematology 1988;41(1):6-11.
1988: Zaccaria A; Tassinari A; Saglio G; Guerrasio A; Testoni N; Celso B; Rosti G; Tura S
Cytogenetic and molecular analyses in Philadelphia chromosome positive acute lymphoblastic leukaemia.
British journal of haematology 1988;69(3):424-6.
1988: Tassinari A; Zaccaria A; Saglio G; Guerrasio A; Testoni N; Celso B; Rosti G; Cambrin G R; Tura S
Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia.
Haematologica 1988;73(4):326-7.
1988: Cavo M; Galieni P; Tassi C; Gobbi M; Tura S
M-2 protocol for melphalan-resistant and relapsing multiple myeloma.
European journal of haematology 1988;40(2):168-73.
1988: Tura S; Finelli C; Bandini G; Cavo M; Gobbi M
Cyclosporin A in the treatment of CLL associated PRCA and bone marrow hypoplasia.
Nouvelle revue française d'hématologie 1988;30(5-6):479-81.
1987: Finelli C; Bandini G; Ricci P; Giudice V; Vianelli N; Rabbi C; Raspadori D; Tura S
Ciclosporin A in idiopathic and CLL-associated pure red cell aplasia.
Haematologica 1987;72(6):537-40.
1987: Santucci M A; Visani G; Motta M R; Rizzi S; Perocco P; Tosi P; Baccarani M; Colombini R; Tura S
Effect of etoposide (VP 16-213) on normal CFU-GM growth pattern.
Haematologica 1987;72(6):493-9.
1987: Tazzari P L; Gobbi M; Dinota A; Bontadini A; Grassi G; Cerato C; Cavo M; Pileri S; Caligaris-Cappio F; Tura S
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.
Clinical and experimental immunology 1987;70(1):192-200.
1987: Baccarani M; Tazzari P L; Motta M R; Rizzi S; Fanin R; Fasola G; Damiani D; Dinota A; Tura S
Cell kinetic effect of low dose arabinosyl cytosine.
British journal of haematology 1987;67(1):33-7.
1987: Zaccaria A; Testoni N; Celso B; Emiliani E; Barbieri E; Tura S
Increasing doses of 60Co ionizing radiation produce different amounts of dicentrics depending on the dose rate. A possible model for irradiation schedules before bone marrow transplantation.
Haematologica 1987;72(4):297-9.
1987: Guarini A; Mussoni L; Gugliotta L; Chetti L; Niewiarowski T; Catani L; Macchi S; Donati M B; Tura S
Depressed fibrinolysis in patients with acute leukaemia.
British journal of haematology 1987;66(3):327-30.
1987: Gugliotta L; Macchi S; Catani L; Chetti L; Mattioli Belmonte M; Guarini A; Criscuolo D; Tura S
Recombinant alpha-2a interferon (alpha-IFN) in the treatment of essential thrombocythaemia. Preliminary report.
Haematologica 1987;72(3):277-9.
1987: Guarini A; Gugliotta L; Catani L; Chetti L; Macchi S; Tura S
Procoagulant cellular activity (PCA) in the classification of acute leukemia.
Thrombosis research 1987;45(5):545-52.
1987: Rosti G; Zaccaria A; Testoni N; Celso B; Ricci P; Bandini G; Baccarani M; Tura S
Chromosome patterns of relapses following allogeneic bone marrow transplantation for acute non-lymphocytic leukemia. Description of three cases.
Haematologica 1987;72(2):111-4.
1986: Tura S; Mazza P; Zinzani P L; Verlicchi F; Baccarani M; Lauria F; Fiacchini M; Gobbi M; Bandini G; Emiliani E
Hodgkin's disease (HD): a historical perspective.
European journal of cancer & clinical oncology 1986;22(11):1315-23.
1986: Tura S
Bone marrow transplantation in multiple myeloma: current status and future perspectives.
Bone marrow transplantation 1986;1(1):17-20.
1986: Guarini A; Gugliotta L; Valvassori L; Bagnara G P; Timoncini C; Motta M R; Chetti L; Catani L; Russo D; Tura S
Human myeloid precursor cells do not possess or produce procoagulant activity (PCA).
Experimental hematology 1986;14(1):72-4.
1985: Lauria F; Foa R; Raspadori D; Motta M R; Tazzari P L; Biagini G; Preda P; Algeri R; Tura S
T-cell prolymphocytic leukaemia: a clinical and immunological study.
Scandinavian journal of haematology 1985;35(3):319-24.
1985: Guarini A; Gugliotta L; Timoncini C; Chetti L; Catani L; Russo D; Tura S
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia.
Scandinavian journal of haematology 1985;34(2):152-6.
1984: Mazza P; Miniaci G; Lauria F; Gobbi M; Emiliani E; Barbieri E; Neri S; Querzani P; Fiacchini M; Tura S
Prognostic significance of lymphography in stage IIIs Hodgkin's disease (HD).
European journal of cancer & clinical oncology 1984;20(11):1393-9.
1981: Baccarani M; Marini M; Bagnara G P; Gobbi M; Saviotti F; Brunelli M A; Tura S
TdT in adult acute lymphoblastic leukemia: relationship with blast cell count.
Haematologica 1981;66(5):579-87.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Sante Tura

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Sante Tura (preview)

All Publications